SEC Form 4 · accession 0001178913-18-000771
Foamix Pharmaceuticals Ltd. · FOMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russell P. Elliott
Officer — VP Drug Development
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 11:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606645
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 2, 2018 | S | 817 | $6.14 | D | 12,868 | D |
Table II — derivative securities
No Table II lines on this filing.